Since small molecules targeting survivin expression are sensitized to TRAIL-mediated apoptosis in cancer cells [13,14,15,16,17], we investigated whether fascaplysin enhances the anti-cancer effect of TRAIL in multiple types of cancer cells. The gene discussed is BIRC5; the disease is cancer.